Cabotegravir (Apretude) for HIV-1 pre-exposure prophylaxis

Med Lett Drugs Ther. 2022 Feb 21;64(1644):29-31.
No abstract available

Keywords: Apretude; Cabenuva; Descovy; HIV; Truvada; adverse effects; cabotegravir; dosage; drug interactions; efficacy; emtricitabine; emtricitiabine/tenofovir; lactation; pregnancy; rilpivirine; safety; tenofovir alafenamide.

MeSH terms

  • Diketopiperazines / administration & dosage*
  • Diketopiperazines / adverse effects
  • Diketopiperazines / economics
  • Diketopiperazines / pharmacology
  • Drug Interactions
  • HIV Infections / prevention & control*
  • HIV Integrase Inhibitors / administration & dosage*
  • HIV Integrase Inhibitors / adverse effects
  • HIV Integrase Inhibitors / economics
  • HIV Integrase Inhibitors / pharmacology
  • HIV-1
  • Humans
  • Pre-Exposure Prophylaxis
  • Pyridones / administration & dosage*
  • Pyridones / adverse effects
  • Pyridones / economics
  • Pyridones / pharmacology

Substances

  • Diketopiperazines
  • HIV Integrase Inhibitors
  • Pyridones
  • cabotegravir